General Discussion
In reply to the discussion: New Pharma Bros Strike: This time it's the EpiPen. . . Up 450%, from $50 to $600 for a 2-pack. [View all]sharp_stick
(14,400 posts)company this disgusts the hell out of me.
I can also say, after talking with a lot of other scientists in my company and in the industry as a whole it disgusts damn near all of them too.
Most of these companies aren't "pharma" as we use the term in that they don't actually make medicine, at least not new medicine. They can't use the "R&D is expensive" line because they don't have R&D. Generics used to be all about saving money and producing in quantity but they figured out that if not enough companies are making a product they have a captive audience. Scumbags plain and simple. It's not enough to make money, they have to always make more money.
This is marketing and business departments run amok. I know it's been brought up at a couple of our company wide meetings and the bosses at least know that we don't want to be in the same field as these dirtbags.
Now, that being said, you might be able to help yourself if you use the savings card. I haven't looked into this one specifically but I use one for a different medicine and it's reduced my copay to zero.
https://www.epipen.com/copay-offer/